Examples include inhibitors of angiotensin-converting enzyme (ACE) and dipeptidyl peptidase-4 (DPP-4)
Given the heterogeneity of kratom consumers, the array of products, and limitations in current assessment and testing methods, clinicians may not be equipped for evidence-based practice with respect to patients who use kratom or who may have DSM-5-derived kratom use disorder (KUD)
This extended duration makes it valuable for studies investigating sustained metabolic effects
Diarrhea is one of the most commonly reported side effects in retatrutide clinical trials, affecting anywhere from 9% to 35% of participants depending on dose level and study phase
Authors of the report are Robert Bozick, Shannon Donofry and Katherine M
From medically supervised weight loss to holistic wellness initiatives, you have every resource at your fingertips